Phacoemulsification tips
A family of patented flexible and expandable phaco tip designs (2021–2025) rethinking the instrument at the heart of cataract surgery.
Innovation
Built for the operating room
Ten patents, a shelf of first-in-the-U.S. implants, and advisory work with the companies defining anterior-segment care. The through-line is the same: instruments and technology judged by what they do at the microscope.
First-in-the-U.S. adoption
Among the first American surgeons to implant the Light Adjustable Lens, iStent, and Hydrus — bringing new technology to Cleveland patients first.
Industry advisory
Advisor and board roles with device and pharmaceutical innovators shaping the next generation of anterior-segment care.
Patent portfolio
Ten patents, two programs
The phacoemulsification handpiece is the tool at the center of every cataract operation. Between 2021 and 2025 Dr. Wiley filed a family of designs reconsidering its tip — flexible and expandable geometries intended to change how the instrument behaves inside the eye.
A second program covers the pharmaceutical side of surgery: compositions for needle-free surgical sedation (2018–2020, co-invented with John Berdahl, MD and Mark Baum, assigned to Melt Pharmaceuticals) and, most recently, methods for extending the shelf-life of ophthalmic pharmaceutical compositions (2026, Harrow).
A full patent schedule with numbers, filing dates, and assignees is available on request.
15
issued patents covering ophthalmic surgical instruments, devices, and pharmaceutical compositions
- Focus
- Phacoemulsification tip design — and pharmaceutical compositions for surgical sedation
- Filing window
- 2018 – 2026
- Category
- Ophthalmic surgical instruments, devices & pharmaceutical compositions
First in the United States
Technology, adopted early
Each of these implants arrived in the U.S. market with an adoption curve. Dr. Wiley was at the front of it — which meant Cleveland patients were among the first in the country to receive them.
Light Adjustable Lens
Among the first surgeons in the United States to implant the light-adjustable intraocular lens, allowing refractive outcomes to be tuned after surgery.
iStent
Early U.S. adopter of micro-invasive glaucoma surgery, combining stent implantation with cataract removal.
Hydrus Microstent
Early U.S. adopter of the Hydrus microstent for the surgical management of open-angle glaucoma.